BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 27513368)

  • 1. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
    Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Kim SW; Rhee CK; Kim YJ; Lee S; Kim HJ; Lee JW
    Respir Res; 2016 May; 17(1):63. PubMed ID: 27229850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic role of FEV1 for survival in bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
    Ahn JH; Jo KW; Song JW; Shim TS; Lee SW; Lee JS; Kim DY; Lee JH; Lee JH; Choi Y; Lee KH
    Clin Transplant; 2015 Dec; 29(12):1133-9. PubMed ID: 26383085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
    Ruttens D; Verleden SE; Demeyer H; Van Raemdonck DE; Yserbyt J; Dupont LJ; Vanaudenaerde BM; Vos R; Verleden GM
    PLoS One; 2018; 13(4):e0193564. PubMed ID: 29624575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients.
    Norman BC; Jacobsohn DA; Williams KM; Au BK; Au MA; Lee SJ; Moravec CK; Chien JW
    Bone Marrow Transplant; 2011 Oct; 46(10):1369-73. PubMed ID: 21132024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.
    Porhownik NR; Batobara W; Kepron W; Unruh HW; Bshouty Z
    Can Respir J; 2008; 15(4):199-202. PubMed ID: 18551201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Barbosa EJM; Lanclus M; Vos W; Van Holsbeke C; De Backer W; De Backer J; Lee J
    Acad Radiol; 2018 Sep; 25(9):1201-1212. PubMed ID: 29472146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
    Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE; Cowen EW; Justus DG; Baird K; Cheng GS; Avila D; Steinberg SM; Mitchell SA; Gress RE
    Transplant Cell Ther; 2022 May; 28(5):264.e1-264.e9. PubMed ID: 35114411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
    Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Lower Respiratory Tract Infections and Community-Acquired Respiratory Viruses in Patients with Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: A Retrospective Cohort Study.
    Epstein DJ; Liang EC; Sharifi H; Lai YK; Arai S; Graber-Naidich A; Sundaram V; Nelson J; Hsu JL
    Transplant Cell Ther; 2022 Oct; 28(10):705.e1-705.e10. PubMed ID: 35872303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.
    Kwok WC; Liang BM; Lui MMS; Tam TCC; Sim JPY; Tse EWC; Leung AYH; Kwong YL; Lie AKW; Ip MSM; Lam DCL
    Respirology; 2019 May; 24(5):459-466. PubMed ID: 30663178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inert Gas Washout in Bronchiolitis Obliterans Following Hematopoietic Cell Transplantation.
    Nyilas S; Baumeler L; Tamm M; Halter JP; Savic S; Korten I; Meyer A; Singer F; Passweg JR; Latzin P; Stolz D
    Chest; 2018 Jul; 154(1):157-168. PubMed ID: 29275133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Bronchiolitis Obliterans Syndrome Using Nitrogen Multiple Breath Washout in Children Posthemopoietic Stem Cell Transplant.
    Westrupp N; Berry CD; Cole T; Shanthikumar S; Welsh L
    Transplant Cell Ther; 2024 May; 30(5):524.e1-524.e9. PubMed ID: 38360272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung hyperinflation quantitated by chest CT in children with bronchiolitis obliterans syndrome following allogeneic hematopoietic cell transplantation.
    Moutafidis D; Gavra M; Golfinopoulos S; Oikonomopoulou C; Kitra V; Woods JC; Kaditis AG
    Clin Imaging; 2021 Jul; 75():97-104. PubMed ID: 33515927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.